Programmed necrosis and necroptosis signalling

FEBS Journal

Volumn 282, Issue 1, 2015, Pages 19-31

  Feoktistova, Maria ^a   Leverkus, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

cellular FLICE inhibitory protein (cFLIP) isoforms; necroptosis; receptor interacting serine threonine protein kinase 1; receptor interacting serine threonine protein kinase 3; ripoptosome

Indexed keywords

CELL PROTEIN; MIXED LINEAGE KINASE DOMAIN LIKE PROTEIN; RECEPTOR INTERACTING SERINE THREONINE PROTEIN KINASE 1; RECEPTOR INTERACTING SERINE THREONINE PROTEIN KINASE 3; UNCLASSIFIED DRUG; CARRIER PROTEIN; DEATH RECEPTOR; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MULTIPROTEIN COMPLEX; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; AUTOPHAGY; CELL FATE; CELLULAR PARAMETERS; COMPLEX FORMATION; DOWN REGULATION; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; MOLECULAR DYNAMICS; NECROPTOSIS; NECROSOME; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; RIPOPTOSOME; TISSUE METABOLISM; UBIQUITINATION; ANIMAL; BIOLOGICAL MODEL; METABOLISM; MOUSE; NECROSIS; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; HUMANS; MICE; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MODELS, BIOLOGICAL; MULTIPROTEIN COMPLEXES; NECROSIS; PROTEIN KINASES; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECEPTORS, DEATH DOMAIN; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84920770936     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13120     Document Type: Review

References (90)

1. Galluzzi L, Kepp O, Krautwald S, Kroemer G, &, Linkermann A, (2014) Molecular mechanisms of regulated necrosis. Semin Cell Dev Biol 35, 24-32.
2. Kaczmarek A, Vandenabeele P, &, Krysko DV, (2013) Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 38, 209-223.
3. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA, &, Yuan J, (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1, 112-119.
4. Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang JG, Alvarez-Diaz S, Lewis R, Lalaoui N, Metcalf D, Webb AI, et al,. (2013) The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39, 443-453.
5. Vandenabeele P, Galluzzi L, Vanden Berghe T, &, Kroemer G, (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11, 700-714.
6. Linkermann A, &, Green DR, (2014) Necroptosis. N Engl J Med 370, 455-465.
7. Linkermann A, Brasen JH, Darding M, Jin MK, Sanz AB, Heller JO, De ZF, Weinlich R, Ortiz A, Walczak H, et al,. (2013) Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc Natl Acad Sci USA 110, 12024-12029.
8. Wang YQ, Wang L, Zhang MY, Wang T, Bao HJ, Liu WL, Dai DK, Zhang L, Chang P, Dong WW, et al,. (2012) Necrostatin-1 suppresses autophagy and apoptosis in mice traumatic brain injury model. Neurochem Res 37, 1849-1858.
9. Khan MJ, Rizwan AM, Waldeck-Weiermair M, Karsten F, Groschner L, Riederer M, Hallstrom S, Rockenfeller P, Konya V, Heinemann A, et al,. (2012) Inhibition of autophagy rescues palmitic acid-induced necroptosis of endothelial cells. J Biol Chem 287, 21110-21120.
10. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, et al,. (2012) Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 19, 107-120.
11. Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al,. (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060-1072.
12. Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, &, Vandenabeele P, (2014) Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol 15, 135-147.
13. Fouque A, Debure L, &, Legembre P, (2014) The CD95/CD95L signaling pathway: a role in carcinogenesis. Biochim Biophys Acta 1846, 130-141.
14. Vercammen D, Beyaert R, Denecker G, Goossens V, Van LG, Declercq W, Grooten J, Fiers W, &, Vandenabeele P, (1998) Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 187, 1477-1485.
15. Wu YT, Tan HL, Huang Q, Sun XJ, Zhu X, &, Shen HM, (2011) zVAD-induced necroptosis in L929 cells depends on autocrine production of TNFalpha mediated by the PKC-MAPKs-AP-1 pathway. Cell Death Differ 18, 26-37.
16. Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B, &, Tschopp J, (2000) Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 1, 489-495.
17. Vince JE, Wong WW, Khan N, Feltham R, Chau D, Ahmed AU, Benetatos CA, Chunduru SK, Condon SM, McKinlay M, et al,. (2007) IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 131, 682-693.
18. Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P, Zobel K, Dynek JN, Elliott LO, Wallweber HJ, et al,. (2007) IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 131, 669-681.
19. Gaither A, Porter D, Yao Y, Borawski J, Yang G, Donovan J, Sage D, Slisz J, Tran M, Straub C, et al,. (2007) A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-alpha signaling. Cancer Res 67, 11493-11498.
20. Li L, Thomas RM, Suzuki H, De Brabander JK, Wang X, &, Harran PG, (2004) A small molecule Smac mimic potentiates T. Science 305, 1471-1474.
21. Geserick P, Hupe M, Moulin M, Wong WW, Feoktistova M, Kellert B, Gollnick H, Silke J, &, Leverkus M, (2009) Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. J Cell Biol 187, 1037-1054.
22. Chromik J, Safferthal C, Serve H, &, Fulda S, (2014) Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis. Cancer Lett 344, 101-109.
23. McComb S, Cheung HH, Korneluk RG, Wang S, Krishnan L, &, Sad S, (2012) cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation. Cell Death Differ 19, 1791-1801.
24. Jouan-Lanhouet S, Arshad MI, Piquet-Pellorce C, Martin-Chouly C, Le Moigne-Muller G, Van HF, Takahashi N, Sergent O, Lagadic-Gossmann D, Vandenabeele P, et al,. (2012) TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation. Cell Death Differ 19, 2003-2014.
25. Bianchi K, &, Meier P, (2009) A tangled web of ubiquitin chains: breaking news in TNF-R1 signaling. Mol Cell 36, 736-742.
26. Micheau O, &, Tschopp J, (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181-190.
27. Wong WW, Vince JE, Lalaoui N, Lawlor KE, Chau D, Bankovacki A, Anderton H, Metcalf D, O'Reilly L, Jost PJ, et al,. (2014) cIAPs and XIAP regulate myelopoiesis through cytokine production in an R. Blood 123, 2562-2572.
28. Schworer SA, Smirnova II, Kurbatova I, Bagina U, Churova M, Fowler T, Roy AL, Degterev A, &, Poltorak A, (2014) Toll-like receptor-mediated downregulation of the deubiquitinase CYLD protects macrophages from necroptosis in wild-derived mice. J Biol Chem 289, 14422-14433.
29. Kaiser WJ, Sridharan H, Huang C, Mandal P, Upton JW, Gough PJ, Sehon CA, Marquis RW, Bertin J, &, Mocarski ES, (2013) Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem 288, 31268-31279.
30. Upton JW, Kaiser WJ, &, Mocarski ES, (2012) DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 11, 290-297.
31. Dunai ZA, Imre G, Barna G, Korcsmaros T, Petak I, Bauer PI, &, Mihalik R, (2012) Staurosporine induces necroptotic cell death under caspase-compromised conditions in U937 cells. PLoS One 7, e41945.
32. Tenev T, Bianchi K, Darding M, Broemer M, Langlais C, Wallberg F, Zachariou A, Lopez J, MacFarlane M, Cain K, et al,. (2011) The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 43, 432-448.
33. Rovetta F, Stacchiotti A, Faggi F, Catalani S, Apostoli P, Fanzani A, &, Aleo MF, (2013) Cobalt triggers necrotic cell death and atrophy in skeletal C2C12 myotubes. Toxicol Appl Pharmacol 271, 196-205.
34. Feoktistova M, Geserick P, Kellert B, Dimitrova DP, Langlais C, Hupe M, Cain K, MacFarlane M, Hacker G, &, Leverkus M, (2011) cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 43, 449-463.
35. Jang TH, Zheng C, Li J, Richards C, Hsiao YS, Walz T, Wu H, &, Park HH, (2014) Structural study of the RIPoptosome core reveals a helical assembly for kinase recruitment. Biochemistry 53, 5424-5431.
36. Rickard JA, O'Donnell JA, Evans JM, Lalaoui N, Poh AR, Rogers T, Vince JE, Lawlor KE, Ninnis RL, Anderton H, et al,. (2014) RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 157, 1175-1188.
37. Dillon CP, Weinlich R, Rodriguez DA, Cripps JG, Quarato G, Gurung P, Verbist KC, Brewer TL, Llambi F, Gong YN, et al,. (2014) RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157, 1189-1202.
38. Kaiser WJ, Daley-Bauer LP, Thapa RJ, Mandal P, Berger SB, Huang C, Sundararajan A, Guo H, Roback L, Speck SH, et al,. (2014) RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition. Proc Natl Acad Sci USA 111, 7753-7758.
39. Berger SB, Kasparcova V, Hoffman S, Swift B, Dare L, Schaeffer M, Capriotti C, Cook M, Finger J, Hughes-Earle A, et al,. (2014) Cutting edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. J Immunol 192, 5476-5480.
40. Newton K, Dugger DL, Wickliffe KE, Kapoor N, de Almagro MC, Vucic D, Komuves L, Ferrando RE, French DM, Webster J, et al,. (2014) Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 343, 1357-1360.
41. Kearney CJ, Cullen SP, Clancy D, &, Martin SJ, (2014) RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis. FEBS J 281, 4921-4934.
42. Feoktistova M, Geserick P, Panayotova-Dimitrova D, &, Leverkus M, (2012) Pick your poison: the Ripoptosome, a cell death platform regulating apoptosis and necroptosis. Cell Cycle 11, 460-467.
43. Schilling R, Geserick P, &, Leverkus M, (2014) Characterization of the ripoptosome and its components: implications for anti-inflammatory and cancer therapy. Methods Enzymol 545, 83-102.
44. Li J, McQuade T, Siemer AB, Napetschnig J, Moriwaki K, Hsiao YS, Damko E, Moquin D, Walz T, McDermott A, et al,. (2012) The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150, 339-350.
45. Schleich K, Warnken U, Fricker N, Ozturk S, Richter P, Kammerer K, Schnolzer M, Krammer PH, &, Lavrik IN, (2012) Stoichiometry of the CD95 death-inducing signaling complex: experimental and modeling evidence for a death effector domain chain model. Mol Cell 47, 306-319.
46. Dickens LS, Boyd RS, Jukes-Jones R, Hughes MA, Robinson GL, Fairall L, Schwabe JW, Cain K, &, MacFarlane M, (2012) A death effector domain chain DISC model reveals a crucial role for caspase-8 chain assembly in mediating apoptotic cell death. Mol Cell 47, 291-305.
47. Estornes Y, &, Bertrand MJ, (2014) IAPs, regulators of innate immunity and inflammation. Semin Cell Dev Biol doi: 10.1016/j.semcdb.2014.03.035.
48. Vince JE, Chau D, Callus B, Wong WW, Hawkins CJ, Schneider P, McKinlay M, Benetatos CA, Condon SM, Chunduru SK, et al,. (2008) TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. J Cell Biol 182, 171-184.
49. Vanlangenakker N, Bertrand MJ, Bogaert P, Vandenabeele P, &, Vanden Berghe T, (2011) TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members. Cell Death Dis 2, e230.
50. Steinhart L, Belz K, &, Fulda S, (2013) Smac mimetic and demethylating agents synergistically trigger cell death in acute myeloid leukemia cells and overcome apoptosis resistance by inducing necroptosis. Cell Death Dis 4, e802.
51. Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, Xavier RJ, &, Yuan J, (2008) Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 135, 1311-1323.
52. Moquin DM, McQuade T, &, Chan FK, (2013) CYLD deubiquitinates RIP1 in the TNFalpha-induced necrosome to facilitate kinase activation and programmed necrosis. PLoS One 8, e76841.
53. Bonnet MC, Preukschat D, Welz PS, Van LG, Ermolaeva MA, Bloch W, Haase I, &, Pasparakis M, (2011) The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. Immunity 35, 572-582.
54. Kataoka T, (2005) The caspase-8 modulator c-FLIP. Crit Rev Immunol 25, 31-58.
55. Rasper DM, Vaillancourt JP, Hadano S, Houtzager VM, Seiden I, Keen SL, Tawa P, Xanthoudakis S, Nasir J, Martindale D, et al,. (1998) Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Differ 5, 271-288.
56. Wachter T, Sprick M, Hausmann D, Kerstan A, McPherson K, Stassi G, Brocker EB, Walczak H, &, Leverkus M, (2004) cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-kappaB activation at the death-inducing signaling complex in human keratinocytes. J Biol Chem 279, 52824-52834.
57. Scaffidi C, Schmitz I, Krammer PH, &, Peter ME, (1999) The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 274, 1541-1548.
58. Kavuri SM, Geserick P, Berg D, Dimitrova DP, Feoktistova M, Siegmund D, Gollnick H, Neumann M, Wajant H, &, Leverkus M, (2011) Cellular FLICE-inhibitory protein (cFLIP) isoforms block. J Biol Chem 286, 16631-16646.
59. Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C, Hakem R, Salvesen GS, &, Green DR, (2011) Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471, 363-367.
60. van Raam BJ, Ehrnhoefer DE, Hayden MR, &, Salvesen GS, (2013) Intrinsic cleavage of receptor-interacting protein kinase-1 by caspase-6. Cell Death Differ 20, 86-96.
61. Galluzzi L, Kepp O, &, Kroemer G, (2014) MLKL regulates necrotic plasma membrane permeabilization. Cell Res 24, 139-140.
62. Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, Alnemri ES, Altucci L, Andrews D, &, Annicchiarico-Petruzzelli M, (2014) Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ doi: 10.1038/cdd.2014.137.
63. Moriwaki K, &, Chan FK, (2014) Necrosis-dependent and independent signaling of the RIP kinases in inflammation. Cytokine Growth Factor Rev 25, 167-174.
64. McQuade T, Cho Y, &, Chan FK, (2013) Positive and negative phosphorylation regulates. Biochem J 456, 409-415.
65. Wu J, Huang Z, Ren J, Zhang Z, He P, Li Y, Ma J, Chen W, Zhang Y, Zhou X, et al,. (2013) Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res 23, 994-1006.
66. Sun L, Wang H, Wang Z, He S, Chen S, Liao D, Wang L, Yan J, Liu W, Lei X, et al,. (2012) Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213-227.
67. Cai Z, Jitkaew S, Zhao J, Chiang HC, Choksi S, Liu J, Ward Y, Wu LG, &, Liu ZG, (2014) Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol 16, 55-65.
68. Chen X, Li W, Ren J, Huang D, He WT, Song Y, Yang C, Li W, Zheng X, Chen P, et al,. (2014) Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res 24, 105-121.
69. Wang H, Sun L, Su L, Rizo J, Liu L, Wang LF, Wang FS, &, Wang X, (2014) Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell 54, 133-146.
70. Dondelinger Y, Declercq W, Montessuit S, Roelandt R, Goncalves A, Bruggeman I, Hulpiau P, Weber K, Sehon CA, Marquis RW, et al,. (2014) MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep 7, 971-981.
71. Cullen SP, Henry CM, Kearney CJ, Logue SE, Feoktistova M, Tynan GA, Lavelle EC, Leverkus M, &, Martin SJ, (2013) Fas/CD95-induced chemokines can serve as "find-me" signals for apoptotic cells. Mol Cell 49, 1034-1048.
72. Carneiro LA, Travassos LH, Soares F, Tattoli I, Magalhaes JG, Bozza MT, Plotkowski MC, Sansonetti PJ, Molkentin JD, Philpott DJ, et al,. (2009) Shigella induces mitochondrial dysfunction and cell death in nonmyleoid cells. Cell Host Microbe 5, 123-136.
73. Robinson N, McComb S, Mulligan R, Dudani R, Krishnan L, &, Sad S, (2012) Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat Immunol 13, 954-962.
74. Upton JW, Kaiser WJ, &, Mocarski ES, (2010) Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7, 302-313.
75. Moujalled DM, Cook WD, Okamoto T, Murphy J, Lawlor KE, Vince JE, &, Vaux DL, (2013) TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1. Cell Death Dis 4, e465.
76. Cook WD, Moujalled DM, Ralph TJ, Lock P, Young SN, Murphy JM, &, Vaux DL, (2014) RIPK1- and RIPK3-induced cell death mode is determined by target availability. Cell Death Differ 21, 1600-1612.
77. Ch'en IL, Tsau JS, Molkentin JD, Komatsu M, &, Hedrick SM, (2011) Mechanisms of necroptosis in T cells. J Exp Med 208, 633-641.
78. Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, Hakem R, Caspary T, &, Mocarski ES, (2011) RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471, 368-372.
79. Dillon CP, Oberst A, Weinlich R, Janke LJ, Kang TB, Ben-Moshe T, Mak TW, Wallach D, &, Green DR, (2012) Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Rep 1, 401-407.
80. Panayotova-Dimitrova D, Feoktistova M, Ploesser M, Kellert B, Hupe M, Horn S, Makarov R, Jensen F, Porubsky S, Schmieder A, et al,. (2013) cFLIP regulates skin homeostasis and protects against TNF-induced keratinocyte apoptosis. Cell Rep 5, 397-408.
81. Weinlich R, Oberst A, Dillon CP, Janke LJ, Milasta S, Lukens JR, Rodriguez DA, Gurung P, Savage C, Kanneganti TD, et al,. (2013) Protective roles for caspase-8 and cFLIP in adult homeostasis. Cell Rep 5, 340-348.
82. Kovalenko A, Kim JC, Kang TB, Rajput A, Bogdanov K, Dittrich-Breiholz O, Kracht M, Brenner O, &, Wallach D, (2009) Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. J Exp Med 206, 2161-2177.
83. Dannappel M, Vlantis K, Kumari S, Polykratis A, Kim C, Wachsmuth L, Eftychi C, Lin J, Corona T, Hermance N, et al,. (2014) RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 513, 90-94.
84. Takahashi N, Vereecke L, Bertrand MJ, Duprez L, Berger SB, Divert T, Goncalves A, Sze M, Gilbert B, Kourula S, et al,. (2014) RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. Nature 513, 95-99.
85. Gunther C, Martini E, Wittkopf N, Amann K, Weigmann B, Neumann H, Waldner MJ, Hedrick SM, Tenzer S, Neurath MF, et al,. (2011) Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis. Nature 477, 335-339.
86. Lau A, Wang S, Jiang J, Haig A, Pavlosky A, Linkermann A, Zhang ZX, &, Jevnikar AM, (2013) RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival. Am J Transplant 13, 2805-2818.
87. Oerlemans MI, Koudstaal S, Chamuleau SA, de Kleijn DP, Doevendans PA, &, Sluijter JP, (2013) Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection. Int J Cardiol 165, 410-422.
88. Rosenbaum DM, Degterev A, David J, Rosenbaum PS, Roth S, Grotta JC, Cuny GD, Yuan J, &, Savitz SI, (2010) Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J Neurosci Res 88, 1569-1576.
89. Chavez-Valdez R, Martin LJ, &, Northington FJ, (2012) Programmed necrosis: a prominent mechanism of cell death following neonatal brain injury. Neurol Res Int 2012, 257563.
90. Jouan-Lanhouet S, Riquet F, Duprez L, Vanden Berghe T, Takahashi N, &, Vandenabeele P, (2014) Necroptosis, in vivo detection in experimental disease models. Semin Cell Dev Biol 35, 2-13.